NCT06774131 2026-01-16
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
UroGen Pharma Ltd.
Phase 3 Recruiting
UroGen Pharma Ltd.
UroGen Pharma Ltd.
First Affiliated Hospital of Wenzhou Medical University